Search

Your search keyword '"Puccini, Alberto"' showing total 331 results
Start Over Author "Puccini, Alberto"
331 results on '"Puccini, Alberto"'

4. Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes

Author

Militello, Anna Maria, Orsi, Giulia, Cavaliere, Alessandro, Niger, Monica, Avallone, Antonio, Salvatore, Lisa, Tortora, Giampaolo, Rapposelli, Ilario Giovanni, Giordano, Guido, Noventa, Silvia, Giommoni, Elisa, Bozzarelli, Silvia, Macchini, Marina, Peretti, Umberto, Procaccio, Letizia, Puccini, Alberto, Cascinu, Stefano, Montagna, Cristina, Milella, Michele, and Reni, Michele

Published
2023
Full Text
View/download PDF

5. Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients.

Author

Orsi, Giulia, Carconi, Catia, Ghiorzo, Paola, Carrera, Paola, Pastorino, Lorenza, Presi, Silvia, Chiaravalli, Marta, Barbieri, Elena, Giordano, Guido, Sciallero, Stefania, Puccini, Alberto, Salvatore, Lisa, Cortesi, Laura, Macchini, Marina, Natalicchio, Maria Iole, Allavena, Eleonora, Pirrone, Chiara, Archibugi, Livia, Dalmasso, Bruna, Bruno, William, Tortora, Giampaolo, Landriscina, Matteo, Capurso, Gabriele, Cascinu, Stefano, Falconi, Massimo, and Reni, Michele

Published
2024
Full Text
View/download PDF

6. PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system

Author

Zimmer, Kai, Kocher, Florian, Untergasser, Gerold, Kircher, Brigitte, Amann, Arno, Baca, Yasmine, Xiu, Joanne, Korn, W. Micheal, Berger, Martin D., Lenz, Heinz-Josef, Puccini, Alberto, Fontana, Elisa, Shields, Anthony F., Marshall, John L., Hall, Michael, El-Deiry, Wafik S., Hsiehchen, David, Macarulla, Teresa, Tabernero, Josep, Pichler, Renate, Khushman, Moh’d, Manne, Upender, Lou, Emil, Wolf, Dominik, Sokolova, Viktorija, Schnaiter, Simon, Zeimet, Alain G., Gulhati, Pat, Widmann, Gerlig, and Seeber, Andreas

Published
2023
Full Text
View/download PDF

8. Reliability of patient-reported toxicities during adjuvant chemotherapy

Author

Cremante, Malvina, Pastorino, Alessandro, Ponzano, Marta, Grassi, Massimiliano, Martelli, Valentino, Puccini, Alberto, Catalano, Fabio, Murianni, Veronica, Iaia, Maria L., Puglisi, Silvia, Gandini, Annalice, Fornarini, Giuseppe, Caprioni, Francesco, Andretta, Valeria, Pessino, Annamaria, Comandini, Danila, Sciallero, Maria S., Mammoliti, Serafina, Sormani, Maria P., and Sobrero, Alberto

Published
2023
Full Text
View/download PDF

10. Highly prognostic signature for stage II colon cancer from the TOSCA trial: The PROSIT study.

Author

Puccini, Alberto, primary, Ferrando, Lorenzo, additional, Mazzarella, Luca, additional, Frige, Gianmaria, additional, Pessino, Anna Maria, additional, Pastorino, Alessandro, additional, Martelli, Valentino, additional, Garuti, Anna, additional, Di Antonio, Veronica, additional, Ballestrero, Alberto, additional, Torri, Valter, additional, Labianca, Roberto, additional, Fassan, Matteo, additional, Lonardi, Sara, additional, Zoppoli, Gabriele, additional, and Sobrero, Alberto F., additional

Published
2024
Full Text
View/download PDF

12. Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center.

Author

Puccini, Alberto, Nardin, Simone, Trevisan, Lucia, Lastraioli, Sonia, Gismondi, Viviana, Ricciotti, Ilaria, Damiani, Azzurra, Bregni, Giacomo, Murialdo, Roberto, Pastorino, Alessandro, Martelli, Valentino, Gandini, Annalice, Mastracci, Luca, Varesco, Liliana, Dono, Maria, Battistuzzi, Linda, Grillo, Federica, and Sciallero, Stefania

Published
2024
Full Text
View/download PDF

13. Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting.

Author

Grillo, Federica, Angerilli, Valentina, Parente, Paola, Vanoli, Alessandro, Luchini, Claudio, Sciallero, Stefania, Puccini, Alberto, Bergamo, Francesca, Lonardi, Sara, Valeri, Nicola, Mastracci, Luca, and Fassan, Matteo

Abstract

Mismatch repair (MMR) immunohistochemical (IHC) evaluation has entered pathology routine practice as the first-line screening method to identify patients with MMR deficient (MMRd)/microsatellite instability (MSI) colorectal cancer (CRC), and its misdiagnosis may significantly impact the personalization of CRC patient care. To determine the prevalence of MMR protein intratumor heterogeneity in real-world practice, we collected a series of 8282 CRCs tested for MMR proteins in the setting of Lynch syndrome universal screening. Four heterogenous cases were also investigated for tumor infiltrating lymphocytes count, MSI status, and consensus molecular subtypes by Nanostring nCounter® Platform. Overall, 1056 (12.8%) CRCs showed a MMR altered status, with 46 cases showing a heterogeneous MMR profile (0.56% of the total, and 4.36% of all MMRd cases). To conclude, the authors make some critical remarks regarding the approach to MMR heterogeneity in clinical practice and routine diagnostics. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

16. A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials

Author

Berger, Martin D., Ning, Yan, Stintzing, Sebastian, Heinemann, Volker, Cao, Shu, Zhang, Wu, Yang, Dongyun, Miyamoto, Yuji, Suenaga, Mitsukuni, Schirripa, Marta, Hanna, Diana L., Soni, Shivani, Puccini, Alberto, Tokunaga, Ryuma, Naseem, Madiha, Battaglin, Francesca, Cremolini, Chiara, Falcone, Alfredo, Loupakis, Fotios, and Lenz, Heinz-Josef

Published
2020
Full Text
View/download PDF

17. Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma

Author

Seeber, Andreas, Zimmer, Kai, Kocher, Florian, Puccini, Alberto, Xiu, Joanne, Nabhan, Chadi, Elliott, Andrew, Goldberg, Richard M., Grothey, Axel, Shields, Anthony F., Battaglin, Francesca, El-Deiry, Wafik S., Philip, Philip A., Marshall, John L., Hall, Michael, Korn, W. Michael, Lenz, Heinz-Josef, Wolf, Dominik, Feistritzer, Clemens, and Spizzo, Gilbert

Published
2020
Full Text
View/download PDF

18. Molecular profile of BRCA-mutated biliary tract cancers

Author

Spizzo, Gilbert, Puccini, Alberto, Xiu, Joanne, Goldberg, Richard M., Grothey, Axel, Shields, Anthony F., Arora, Sukeshi Patel, Khushman, Moh’d, Salem, Mohamed E., Battaglin, Francesca, Baca, Yasmine, El-Deiry, Wafik S., Philip, Philip A., Nassem, Madiha, Hall, Michael, Marshall, John L., Kocher, Florian, Amann, Arno, Wolf, Dominik, Korn, W. Michael, Lenz, Heinz-Josef, and Seeber, Andreas

Published
2020
Full Text
View/download PDF

20. BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer

Author

Grillo, Federica, primary, Paudice, Michele, additional, Pigozzi, Simona, additional, Dono, Maria, additional, Lastraioli, Sonia, additional, Lugaresi, Marialuisa, additional, Bozzano, Silvia, additional, Tognoni, Camilla, additional, Ali, Murad, additional, Sciallero, Stefania, additional, Puccini, Alberto, additional, Fassan, Matteo, additional, and Mastracci, Luca, additional

Published
2024
Full Text
View/download PDF

22. Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients

Author

Puccini, Alberto, Seeber, Andreas, Xiu, Joanne, Goldberg, Richard M., Soldato, Davide, Grothey, Axel, Shields, Anthony F., Salem, Mohamed E., Battaglin, Francesca, Berger, Martin D., El-Deiry, Wafik S., Tokunaga, Ryuma, Naseem, Madiha, Zhang, Wu, Arora, Sukeshi Patel, Khushman, Moh’d M., Hall, Michael J., Philip, Philip A., Marshall, John L., Korn, W. Michael, and Lenz, Heinz-Josef

Published
2021
Full Text
View/download PDF

23. Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients

Author

Naseem, Madiha, Cao, Shu, Yang, Dongyun, Millstein, Joshua, Puccini, Alberto, Loupakis, Fotios, Stintzing, Sebastian, Cremolini, Chiara, Tokunaga, Ryuma, Battaglin, Francesca, Soni, Shivani, Berger, Martin D., Barzi, Afsaneh, Zhang, Wu, Falcone, Alfredo, Heinemann, Volker, and Lenz, Heinz-Josef

Published
2021
Full Text
View/download PDF

25. Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3

Author

Puccini, Alberto, Loupakis, Fotios, Stintzing, Sebastian, Cao, Shu, Battaglin, Francesca, Togunaka, Ryuma, Naseem, Madiha, Berger, Martin D., Soni, Shivani, Zhang, Wu, Mancao, Christoph, Salhia, Bodour, Mumenthaler, Shannon M., Weisenberger, Daniel J., Liang, Gangning, Cremolini, Chiara, Heinemann, Volker, Falcone, Alfredo, Millstein, Joshua, and Lenz, Heinz-Josef

Published
2019
Full Text
View/download PDF

28. BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer.

Author

Grillo, Federica, Paudice, Michele, Pigozzi, Simona, Dono, Maria, Lastraioli, Sonia, Lugaresi, Marialuisa, Bozzano, Silvia, Tognoni, Camilla, Ali, Murad, Sciallero, Stefania, Puccini, Alberto, Fassan, Matteo, and Mastracci, Luca

Subjects
HEREDITARY nonpolyposis colorectal cancer, BRAF genes, COLORECTAL cancer, MEDICAL screening, IMMUNOHISTOCHEMISTRY, MOLECULAR pathology
Abstract

Aims: The Lynch syndrome (LS) screening algorithm requires BRAF testing as a fundamental step to distinguish sporadic from LS‐associated colorectal carcinomas (CRC). BRAF testing by immunohistochemistry (IHC) has shown variable results in the literature. Our aim was to analyse concordance between BRAFV600EIHC and BRAF molecular analysis in a large, mono‐institutional CRC whole‐slide, case series with laboratory validation. Methods and results: MisMatch repair (MMR) protein (hMLH1, hPMS2, hMSH2, and hMSH6) and BRAFV600EIHC were performed on all unselected cases of surgically resected CRCs (2018–2023). An in‐house validation study for BRAFV600EIHC was performed in order to obtain optimal IHC stains. BRAFVV600EIHC was considered negative (score 0), positive (scores 2–3), and equivocal (score 1). Interobserver differences in BRAFV600EIHC scoring were noted in the first 150 cases prospectively collected. Nine‐hundred and ninety CRCs cases (830 proficient (p)MMR/160 deficient (d)MMR) were included and all cases performed BRAFV600EIHC (BRAFV600EIHC‐positive 13.5% of all series; 66.3% dMMR cases; 3.4% pMMR cases), while 333 also went to BRAF mutation analysis. Optimal agreement in IHC scoring between pathologists (P < 0.0001) was seen; concordance between BRAFV600EIHC and BRAF molecular analysis was extremely high (sensitivity 99.1%, specificity 99.5%; PPV 99.1%, and NPV 99.5%). Discordant cases were reevaluated; 1 score 3 + IHC/wildtype case was an interpretation error and one score 0 IHC/mutated case was related to heterogenous BRAFV600EIHC expression. Among the 12 IHC‐equivocal score 1+ cases (which require BRAF molecular analysis), three were BRAF‐mutated and nine BRAF‐wildtype. Conclusion: BRAFV600EIHC can be used as a reliable surrogate of molecular testing after stringent in‐house validation. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

33. #412 Pembrolizumab in metastatic cancer patients with microsatellite instability: subgroup analysis on endometrial cancer patients, results from a single center study

Author

Puglisi, Silvia, primary, Cremante, Malvina, additional, Lagodin D’Amato, Agostina, additional, Catalano, Fabio, additional, Gandini, Annalice, additional, Damassi, Alessandra, additional, Murianni, Veronica, additional, Pirrone, Chiara, additional, Martelli, Valentino, additional, Grassi, Massimiliano, additional, Andretta, Valeria, additional, Pessino, Annamaria, additional, Sciallero, Stefania, additional, Comandini, Danila, additional, Pastorino, Alessandro, additional, Fornarini, Giuseppe, additional, Puccini, Alberto, additional, Caprioni, Francesco, additional, Sobrero, Alberto Felice, additional, and Mammoliti, Serafina, additional

Published
2023
Full Text
View/download PDF

34. Total Neoadjuvant Treatment for Locally Advanced Rectal Cancer Patients: Where Do We Stand?

Author

Daprà, Valentina, primary, Airoldi, Marco, additional, Bartolini, Michela, additional, Fazio, Roberta, additional, Mondello, Giuseppe, additional, Tronconi, Maria Chiara, additional, Prete, Maria Giuseppina, additional, D’Agostino, Giuseppe, additional, Foppa, Caterina, additional, Spinelli, Antonino, additional, Puccini, Alberto, additional, and Santoro, Armando, additional

Published
2023
Full Text
View/download PDF

38. Lynch Syndrome: From Multidisciplinary Management to Precision Prevention.

Author

Dal Buono, Arianna, Puccini, Alberto, Franchellucci, Gianluca, Airoldi, Marco, Bartolini, Michela, Bianchi, Paolo, Santoro, Armando, Repici, Alessandro, and Hassan, Cesare

Subjects
*DIAGNOSIS of hereditary nonpolyposis colorectal cancer, *HEREDITARY nonpolyposis colorectal cancer, *PUBLIC health surveillance, *PEPTIDE vaccines, *IMMUNOTHERAPY, *INDIVIDUALIZED medicine, *GENOTYPES, *SEQUENCE analysis
Abstract

Simple Summary: Lynch syndrome (LS) stands as the predominant inherited cancer condition at present. Currently, surveillance is based on genotype-driven strategies and mostly comprises both invasive and non-invasive medical assessments for early diagnosis. Effective preventive strategies for interrupting the biological sequence of cancer development are yet to be established. Recent findings from randomized controlled trials indicate potential preventive functions of resistant starch and/or aspirin in Lynch syndrome. The use of immunogenic frameshift peptides for vaccination appears to be a promising approach for both treating and preventing Lynch syndrome-associated cancers, based on pre-clinical and early phase 1/2a studies. Background and Aims: Lynch syndrome (LS) is currently one of the most prevalent hereditary cancer conditions, accounting for 3% of all colorectal cancers and for up to 15% of those with DNA mismatch repair (MMR) deficiency, and it was one of the first historically identified. The understanding of the molecular carcinogenesis of LS tumors has progressed significantly in recent years. We aim to review the most recent advances in LS research and explore genotype-based approaches in surveillance, personalized cancer prevention, and treatment strategies. Methods: PubMed was searched to identify relevant studies, conducted up to December 2023, investigating molecular carcinogenesis in LS, surveillance strategies, cancer prevention, and treatment in LS tumors. Results: Multigene panel sequencing is becoming the benchmark in the diagnosis of LS, allowing for the detection of a pathogenic constitutional variant in one of the MMR genes. Emerging data from randomized controlled trials suggest possible preventive roles of resistant starch and/or aspirin in LS. Vaccination with immunogenic frameshift peptides appears to be a promising approach for both the treatment and prevention of LS-associated cancers, as evidenced by pre-clinical and preliminary phase 1/2a studies. Conclusions: Although robust diagnostic algorithms, including prompt testing of tumor tissue for MMR defects and referral for genetic counselling, currently exist for suspected LS in CRC patients, the indications for LS screening in cancer-free individuals still need to be refined and standardized. Investigation into additional genetic and non-genetic factors that may explain residual rates of interval cancers, even in properly screened populations, would allow for more tailored preventive strategies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

42. Supplementary Table S2 from Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

Author

Salem, Mohamed E., primary, Puccini, Alberto, primary, Grothey, Axel, primary, Raghavan, Derek, primary, Goldberg, Richard M., primary, Xiu, Joanne, primary, Korn, W. Michael, primary, Weinberg, Benjamin A., primary, Hwang, Jimmy J., primary, Shields, Anthony F., primary, Marshall, John L., primary, Philip, Philip A., primary, and Lenz, Heinz-Josef, primary

Published
2023
Full Text
View/download PDF

43. Data from Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers

Author

Salem, Mohamed E., primary, Puccini, Alberto, primary, Grothey, Axel, primary, Raghavan, Derek, primary, Goldberg, Richard M., primary, Xiu, Joanne, primary, Korn, W. Michael, primary, Weinberg, Benjamin A., primary, Hwang, Jimmy J., primary, Shields, Anthony F., primary, Marshall, John L., primary, Philip, Philip A., primary, and Lenz, Heinz-Josef, primary

Published
2023
Full Text
View/download PDF

44. Supplementary Data from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets

Author

Kocher, Florian, primary, Puccini, Alberto, primary, Untergasser, Gerold, primary, Martowicz, Agnieszka, primary, Zimmer, Kai, primary, Pircher, Andreas, primary, Baca, Yasmine, primary, Xiu, Joanne, primary, Haybaeck, Johannes, primary, Tymoszuk, Piotr, primary, Goldberg, Richard M., primary, Petrillo, Angelica, primary, Shields, Anthony F., primary, Salem, Mohamed E., primary, Marshall, John L., primary, Hall, Michael, primary, Korn, W. Michael, primary, Nabhan, Chadi, primary, Battaglin, Francesca, primary, Lenz, Heinz-Josef, primary, Lou, Emil, primary, Choo, Su-Pin, primary, Toh, Chee-Keong, primary, Gasteiger, Silvia, primary, Pichler, Renate, primary, Wolf, Dominik, primary, and Seeber, Andreas, primary

Published
2023
Full Text
View/download PDF

45. Supplementary Figure from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets

Author

Kocher, Florian, primary, Puccini, Alberto, primary, Untergasser, Gerold, primary, Martowicz, Agnieszka, primary, Zimmer, Kai, primary, Pircher, Andreas, primary, Baca, Yasmine, primary, Xiu, Joanne, primary, Haybaeck, Johannes, primary, Tymoszuk, Piotr, primary, Goldberg, Richard M., primary, Petrillo, Angelica, primary, Shields, Anthony F., primary, Salem, Mohamed E., primary, Marshall, John L., primary, Hall, Michael, primary, Korn, W. Michael, primary, Nabhan, Chadi, primary, Battaglin, Francesca, primary, Lenz, Heinz-Josef, primary, Lou, Emil, primary, Choo, Su-Pin, primary, Toh, Chee-Keong, primary, Gasteiger, Silvia, primary, Pichler, Renate, primary, Wolf, Dominik, primary, and Seeber, Andreas, primary

Published
2023
Full Text
View/download PDF

46. Supplementary Table from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets

Author

Kocher, Florian, primary, Puccini, Alberto, primary, Untergasser, Gerold, primary, Martowicz, Agnieszka, primary, Zimmer, Kai, primary, Pircher, Andreas, primary, Baca, Yasmine, primary, Xiu, Joanne, primary, Haybaeck, Johannes, primary, Tymoszuk, Piotr, primary, Goldberg, Richard M., primary, Petrillo, Angelica, primary, Shields, Anthony F., primary, Salem, Mohamed E., primary, Marshall, John L., primary, Hall, Michael, primary, Korn, W. Michael, primary, Nabhan, Chadi, primary, Battaglin, Francesca, primary, Lenz, Heinz-Josef, primary, Lou, Emil, primary, Choo, Su-Pin, primary, Toh, Chee-Keong, primary, Gasteiger, Silvia, primary, Pichler, Renate, primary, Wolf, Dominik, primary, and Seeber, Andreas, primary

Published
2023
Full Text
View/download PDF

47. Data from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets

Author

Kocher, Florian, primary, Puccini, Alberto, primary, Untergasser, Gerold, primary, Martowicz, Agnieszka, primary, Zimmer, Kai, primary, Pircher, Andreas, primary, Baca, Yasmine, primary, Xiu, Joanne, primary, Haybaeck, Johannes, primary, Tymoszuk, Piotr, primary, Goldberg, Richard M., primary, Petrillo, Angelica, primary, Shields, Anthony F., primary, Salem, Mohamed E., primary, Marshall, John L., primary, Hall, Michael, primary, Korn, W. Michael, primary, Nabhan, Chadi, primary, Battaglin, Francesca, primary, Lenz, Heinz-Josef, primary, Lou, Emil, primary, Choo, Su-Pin, primary, Toh, Chee-Keong, primary, Gasteiger, Silvia, primary, Pichler, Renate, primary, Wolf, Dominik, primary, and Seeber, Andreas, primary

Published
2023
Full Text
View/download PDF

48. Supplementary Table S3 from A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab

Author

Berger, Martin D., primary, Stintzing, Sebastian, primary, Heinemann, Volker, primary, Cao, Shu, primary, Yang, Dongyun, primary, Sunakawa, Yu, primary, Matsusaka, Satoshi, primary, Ning, Yan, primary, Okazaki, Satoshi, primary, Miyamoto, Yuji, primary, Suenaga, Mitsukuni, primary, Schirripa, Marta, primary, Hanna, Diana L., primary, Soni, Shivani, primary, Puccini, Alberto, primary, Zhang, Wu, primary, Cremolini, Chiara, primary, Falcone, Alfredo, primary, Loupakis, Fotios, primary, and Lenz, Heinz-Josef, primary

Published
2023
Full Text
View/download PDF

49. Supplementary Table S2 from Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer

Author

Tokunaga, Ryuma, primary, Xiu, Joanne, primary, Johnston, Curtis, primary, Goldberg, Richard M., primary, Philip, Philip A., primary, Seeber, Andreas, primary, Naseem, Madiha, primary, Lo, Jae Ho, primary, Arai, Hiroyuki, primary, Battaglin, Francesca, primary, Puccini, Alberto, primary, Berger, Martin D., primary, Soni, Shivani, primary, Zhang, Wu, primary, Hwang, Jimmy J., primary, Shields, Anthony F., primary, Marshall, John L., primary, Baba, Hideo, primary, Korn, W. Michael, primary, and Lenz, Heinz-Josef, primary

Published
2023
Full Text
View/download PDF

50. Supplementary Figure S1 from Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer

Author

Tokunaga, Ryuma, primary, Xiu, Joanne, primary, Johnston, Curtis, primary, Goldberg, Richard M., primary, Philip, Philip A., primary, Seeber, Andreas, primary, Naseem, Madiha, primary, Lo, Jae Ho, primary, Arai, Hiroyuki, primary, Battaglin, Francesca, primary, Puccini, Alberto, primary, Berger, Martin D., primary, Soni, Shivani, primary, Zhang, Wu, primary, Hwang, Jimmy J., primary, Shields, Anthony F., primary, Marshall, John L., primary, Baba, Hideo, primary, Korn, W. Michael, primary, and Lenz, Heinz-Josef, primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results